Abstract
Facial rhytides of the upper one third of the face are common aesthetic concerns, and are caused principally by overactivity of the underlying facial musculature. Botulinum toxin, which acts by causing flaccid paralysis of facial mimetic muscles, has become a treatment of choice for the management of these hyperfunctional facial lines. Two antigenically distinct serotypes have been developed and are currently available for commercial use in the United States. There are major differences between the two toxins in terms of pharmacology and formulation that account for clinical differences, and precise interconversion is not well-established. Nevertheless, in these preliminary studies, Myobloc seems to have a faster onset of action and potentially a more even and smoother paralysis. The shorter duration of action of Myobloc seems to be dose-related. It is clear that both agents safely and effectively reduce dynamic facial rhytides. Based on individual efficacy, safety, diffusion pattern, onset, and duration, ultimately, with further trials and clinical experience, it is conceivable that each toxin will have its own set of indications.
References
Jan 1, 1992·The Journal of Dermatologic Surgery and Oncology·J D Carruthers, J A Carruthers
Nov 1, 1988·Neurology·R K OlneyD H Lowenstein
Jan 1, 1986·Annual Review of Pharmacology and Toxicology·L L Simpson
Jan 1, 1982·Pharmacology & Therapeutics·G Sakaguchi
Sep 1, 1995·Neurology·J Jankovic, K Schwartz
Jul 1, 1994·Plastic and Reconstructive Surgery·M KeenM Brin
Apr 1, 1994·Plastic and Reconstructive Surgery·B Guyuron, S W Huddleston
Mar 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·P GreeneB Diamond
Sep 1, 1993·Archives of Otolaryngology--head & Neck Surgery·A BlitzerJ E Aviv
Sep 1, 1993·Neurology·M ZuberP Rondot
Oct 26, 1999·Neurology·M F BrinM Koller
Oct 26, 1999·Neurology·A BrashearM Koller
Mar 7, 2001·JAMA : the Journal of the American Medical Association·S S ArnonUNKNOWN Working Group on Civilian Biodefense
Jun 23, 2001·Plastic and Reconstructive Surgery·S L Matarasso, A Matarasso
Jul 28, 2001·Seminars in Cutaneous Medicine and Surgery·J E CallawayA J Grethlein
Jun 21, 2002·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Alexander L RamirezCorey S Maas
Jun 25, 2002·Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology·Nicholas J LoweDonna Moore
Jun 25, 2002·Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology·James M SpencerDavid J Goldberg
Sep 25, 2002·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Neil S Sadick, Faacs
Jan 22, 2003·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Seth L Matarasso
May 20, 2003·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Neil S Sadick
May 20, 2003·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Doris Maria HexselDêbora Zechmeister
Sep 25, 1959·Science·C LAMANNA
Citations
Dec 20, 2005·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Andrew Blitzer
Nov 26, 2013·Dermatologic Clinics·Andrew DorizasNeil S Sadick
Aug 23, 2011·The Journal of Hand Surgery·Brian A JanzKenneth R Means
Dec 5, 2009·International Journal of Oral and Maxillofacial Surgery·O W Majid
Mar 17, 2009·Disease-a-month : DM·Dave W Lu, Jonathan Lippitz
Jul 4, 2007·American Journal of Otolaryngology·Robert Todd Adelson
Jan 11, 2007·Survey of Ophthalmology·Jonathan J Dutton, Amy M Fowler
Feb 22, 2011·Journal of Cosmetic Dermatology·Amir FeilyHossein Kalantar
Nov 18, 2014·Journal of Cosmetic Dermatology·Andrew YaworskySomali M Burgess
Jun 23, 2005·International Ophthalmology Clinics·Geva E Mannor
Dec 22, 2009·Expert Review of Neurotherapeutics·Frank J LebedaUma Mudunuri